4/A: Elicio Therapeutics Director Files Amended Form 4 to Correctly Report Warrant Ownership
SEC Filing (Form 4/A)
Jay Venkatesan, a director of Elicio Therapeutics, filed an amended Form 4 to correct a previous filing regarding the acquisition of common and pre-funded warrants.
Summary
- Jay Venkatesan, a director of Elicio Therapeutics, filed an amended Form 4 on January 2, 2025, to correct a previous filing made on July 2, 2024.
- The original filing incorrectly reported the acquisition of an additional 150,000 common warrants and 150,000 pre-funded warrants.
- The amended filing clarifies that Venkatesan is not the beneficial owner of these additional warrants.
- As of January 2, 2025, Venkatesan owns 50,000 common warrants exercisable at $5.00 per share and 50,000 pre-funded warrants exercisable at $0.01 per share.
- Both types of warrants are subject to a post-exercise beneficial ownership limitation of 4.99%.
Sentiment
Score: 7
Explanation: The sentiment is neutral. It's a correction of a previous filing, indicating a procedural adjustment rather than a reflection of the company's performance or outlook. The correction itself is a positive sign of diligence.
Negatives
- The need for an amended filing suggests an initial error in reporting warrant ownership.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency in the market.
Stakeholder Impact
- The correction of the Form 4 filing ensures accurate information for shareholders regarding insider ownership.
Key Dates
| Date | Description |
|---|---|
| 06/28/2024 | Date of earliest transaction (warrant acquisition). |
| 07/01/2024 | Common and Pre-Funded Warrants will be exercisable on or after this date. |
| 07/02/2024 | Date of original Form 4 filing (incorrect). |
| 07/01/2029 | Expiration date of the Common Warrants. |
| 01/02/2025 | Date of amended Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.